Literature DB >> 14517641

Comparative effect of 6% hydroxyethyl starch (containing 1% dextrose) and lactated Ringer's solution for cesarean section under spinal anesthesia.

Tomoko Yorozu1, Hiroshi Morisaki, Masahiro Kondoh, Misako Zenfuku, Toshiyuki Shigematsu.   

Abstract

PURPOSE: This study aimed to compare low-molecular weight hydroxyethyl starch containing 1% dextrose (HES) infusion and lactated Ringer's solution (LR) in the prevention of hypotension associated with spinal anesthesia for cesarean section.
METHODS: Sixty-seven patients scheduled for cesarean section under spinal anesthesia were randomly allocated to receive either LR ( n= 35) or HES ( n= 32) infusion before cesarean delivery. Infusion of the fluid was started immediately after arrival at the operating room, through two fully open i.v. routes of 18 or 16 gauge. The two groups were compared in terms of the incidence of hypotension; ephedrine dose; cord and maternal blood gas, hemoglobin, and glucose; and Apgar scores.
RESULTS: Intravenous fluid volume until delivery in the LR group was significantly greater than that in the HES group (1298 +/- 503 and 973 +/- 339 ml, respectively) in spite of the similar periods of intravenous infusion (18.1 +/- 3.9 and 18.2 +/- 4.1 min). The incidence of hypotension, and the ephedrine dose, blood gas analyses, and Apgar scores were not significantly different between the groups. The ephedrine dose correlated with the anesthesia level by spinal anesthesia (P < 0.05).
CONCLUSION: This study did not show an advantage of HES compared with LR in the prevention of hypotension or in the reduction of ephedrine dose during cesarean section under spinal anesthesia. The anesthesia level, rather than the choice of intravenous fluid solution, might be related to the ephedrine dose.

Entities:  

Year:  2002        PMID: 14517641     DOI: 10.1007/s005400200025

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  7 in total

1.  Intrathecal low-dose levobupivacaine and bupivacaine combined with fentanyl in a randomised controlled study for caesarean section: blockade characteristics, maternal and neonatal effects.

Authors:  K Misirlioglu; Gu Sivrikaya; A Hanci; A Yalcinkaya
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

2.  Influence of administration of 1 % glucose solution on neonatal blood glucose concentration in cesarean section.

Authors:  Tomoaki Yatabe; Hiroki Tateiwa; Nobuo Ikenoue; Sonoe Kitamura; Koichi Yamashita; Masataka Yokoyama
Journal:  J Anesth       Date:  2012-11-07       Impact factor: 2.078

3.  Techniques for preventing hypotension during spinal anaesthesia for caesarean section.

Authors:  Cheryl Chooi; Julia J Cox; Richard S Lumb; Philippa Middleton; Mark Chemali; Richard S Emmett; Scott W Simmons; Allan M Cyna
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

4.  Level of sensory block after spinal anesthesia as a predictor of hypotension in parturient.

Authors:  Ning Zhang; Liangliang He; Jia-Xiang Ni
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

5.  Effect of Glucose Containing Crystalloid Infusion on Maternal Hemodynamic Status After Spinal Anesthesia for Cesarean Section.

Authors:  Simin Atashkhoei; Reyhaneh Abri; Bahman Naghipour; Pouya Hatami Marandi; Mohammad Taher Fazeli Danesh
Journal:  Anesth Pain Med       Date:  2018-08-25

6.  Colloid preloading versus crystalloid preloading to prevent hypotension after spinal anesthesia for cesarean delivery: A protocol for systematic review and meta-analysis.

Authors:  Yuchao Shang; Huafeng Li; Junmei Ma; Ling Tan; Shuying Li; Ping Li; Bo Sheng; Rurong Wang
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

7.  Fluid loading therapy to prevent spinal hypotension in women undergoing elective caesarean section: Network meta-analysis, trial sequential analysis and meta-regression.

Authors:  Koen Rijs; Frédéric J Mercier; D Nuala Lucas; Rolf Rossaint; Markus Klimek; Michael Heesen
Journal:  Eur J Anaesthesiol       Date:  2020-12       Impact factor: 4.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.